A Radiation Therapy Oncology Group trial shows that, in adults with an oligodendroglioma brain tumor, a chromosomal abnormality is associated with a near-doubling of median survival time and better prognosis when patients are treated with combined chemotherapy and radiation therapy compared to radiation therapy alone.